<i>Limosilactobacillus reuteri</i> BIO7251 administration improves metabolic phenotype in obese mice fed a high fat diet: an inter-organ crosstalk between gut, adipose tissue and nervous system-Reference-Cited by-同舟云学术

Limosilactobacillus reuteri BIO7251 administration improves metabolic phenotype in obese mice fed a high fat diet: an inter-organ crosstalk between gut, adipose tissue and nervous system

Published:2023-11-03 Issue: Volume: Page:1-12
ISSN:0963-7486
Container-title:International Journal of Food Sciences and Nutrition
language:en
Short-container-title:International Journal of Food Sciences and Nutrition

Author:

Abot Anne¹,Pomié Nicolas¹,Astre Gwendoline¹,Jaomanjaka Fety²,Marchand Pierre²,Cani Patrice D.³⁴^ORCID,Roudier Nathalie²,Knauf Claude⁵^ORCID

Affiliation:

1. Enterosys SAS, Labège, France

2. Bioprox Healthcare, Levallois-Perret, France

3. UCLouvain, Université catholique de Louvain, Brussels, NeuroMicrobiota, International Research Program (IRP) INSERM/UCLouvain, France/Belgium, Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI), Brussels, Belgium

4. WELBIO-Walloon Excellence in Life Sciences and Biotechnology (WELBIO) department, WEL Research Institute (WELRI), Brussels, Belgium

5. NeuroMicrobiota, International Research Program (IRP) INSERM/UCLouvain, INSERM U1220, Institut de Recherche en Santé Digestive (IRSD), Université Paul Sabatier, Toulouse III, CHU Purpan, Toulouse, France

Funder

Biodis

BPIfrance

Publisher

Informa UK Limited

Subject

Food Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/09637486.2023.2276672

Reference26 articles.

1. Reactive Oxygen Species/Reactive Nitrogen Species as Messengers in the Gut: Impact on Physiology and Metabolic Disorders

2. Galanin enhances systemic glucose metabolism through enteric Nitric Oxide Synthase-expressed neurons

3. Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice

4. Limosilactobacillus reuteri in Health and Disease

5. Obesity and gut–microbiota–brain axis: A narrative review